NCT05479071 is a clinical trial of Blood test in SLE, sponsored by Assiut University.

Who is sponsoring NCT05479071?

NCT05479071 is sponsored by Assiut University.

What drugs are being tested in NCT05479071?

Interventions in NCT05479071: Blood test.

Is NCT05479071 still recruiting?

NCT05479071 is currently status unknown. Last updated 29 July 2022.

Last reviewed 2022-07-29 · How we verify

NCT05479071

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.

Status unknown Last updated 29 July 2022

What this trial tests

trial testing Blood test in SLE in 100 participants. Status unknown.

Timeline

1 September 2022

Primary endpoint
1 September 2023

1 October 2023

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 September 2022
Primary completion	1 September 2023
Estimated completion	1 October 2023

Drugs / interventions tested

Blood test — full drug profile →

Conditions studied

SLE — all drugs for SLE →

Sponsor

Assiut University

Who can join

Adults 18 to 70, any sex, with SLE. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to correlate the autoantibody against oxidized LDL with disease activity and cardiovascular affection in patients with SLE.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood test

Trials testing the same drug.

NCT06863974 — High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Im · NA · recruiting
NCT07078435 — Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis · NA · not yet recruiting
NCT05370300 — SNAPS Breast Cancer Patient Study Breast Cancer Patients · not yet recruiting
NCT06820450 — Pilot Study to Characterize the Endometriosis Steroidome and Its Link to Endocrine Disruptors and Vaginal Dysbiosis · not yet recruiting
NCT06999785 — Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperba · NA · recruiting

Other recruiting trials for SLE

Currently open trials in the same condition.

NCT07203404 — A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. · EARLY_PHASE1 · recruiting
NCT06839976 — CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus · Phase 1, PHASE2 · recruiting
NCT06775912 — Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases · EARLY_PHASE1 · recruiting
NCT07148115 — Pregnancies Before the Diagnosis of Systemic Lupus Erythematosus · recruiting
NCT05822219 — Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases · NA · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05479071 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 29 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05479071.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing